KYAT1 and hepatocellular carcinoma: To investigate whether the targeted KYAT1 mutations can enhance MSC metabolism, wild-type and each mutant KYAT1 variants were overexpressed in hepatocellular carcinoma (HCC) cell lines (HepG2 and Huh7).